Skip to main content

65 publications

Name Date Type Actions

2014 annual results

Sustained growth, Reference products drive growth in 2014.
<br />
2014 key figures.

24/03/2015 Annual Report

2014 sales up 5.2% to €315.3 million

The Vétoquinol Group posted 2014 sales of €315.3 million, up 5.2% from the previous year. At constant exchange rates, sales rose by 6.3%. The Vétoquinol Group achieved organic growth of 1.4% in 2014.

22/01/2015 Public releases

2015 First half Results

2015 Half year results

30/07/2015 Half Year Report

2016 calendar of financial communication

December 15, 2015 (Lure, France) – Vétoquinol published its calendar of financial communication for 2016.

15/12/2015 Agenda

2023 ANNUAL RESULTS

Annual sales: €529m (stable at constant exchange rates)
Essentials sales: €313m (+4.5% at constant exchange rates)
Net income - Group share: €56m (10.5% of sales)
EBITDA: €113m (21.3% of sales)
Free cash-flow: €89m

20/03/2024 Public releases

2024 Calendar of financial communication

Vetoquinol published its calendar of financial communication for 2024.

03/01/2024 Agenda

ANNUAL RESULTS 2023 (slideshow)

01.2023 Highlights
02.2023 Consolidated financial statements
03.Strategy and outlook

20/03/2024 Annual Report

Annual sales 2023: €529 million

Annual Sales of Essential products: €313 million (up 4.5% at constant exchange rates)

24/01/2024 Public releases

Assemblée Générale Mixte du 20 mai 2015 : exercice 2014

22/05/2015 Shareholders´s Meeting

Availability of the 2023 universal registration document

On 24 April 2024, Vetoquinol filed its 2022 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format).

24/04/2024 Public releases